Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 7INDUSTRY 1

Study Type

Observational 1

Sponsor

Cancer Type

Classical hematology 1

Conditions

Venous Thromboembolism 3Venous Thrombosis 1Thromboembolism 1Pancreatic Neoplasms 1Gastrointestinal Neoplasms 1Carcinoma, Pancreatic Ductal 1Abdominal Neoplasms 1

Interventions

Dalteparin 3apixaban 2abelacimab 2MAA868 2isoquercitrin 1edoxaban 1calcium heparin 1bemiparin 1Tinzaparin 1Rivaroxaban 1Nadroparin 1Heparin, Low-Molecular-Weight 1Heparin 1Fondaparinux 1Enoxaparin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Venous Thrombosis × Enoxaparin × Clear all
NCT01444612 2017-05-16

Comparative Analysis of Injectable Anticoagulants for Thromboprophylaxis Post Cancer-related Surgery

GlaxoSmithKline

Completed
4,068 enrolled
Classical hematology

Venous Thrombosis, Venous Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡